Letitia Pienaar | Pharmaceutical Policy and Regulation | Best Researcher Award

Dr. Letitia Pienaar | Pharmaceutical Policy and Regulation | Best Researcher Award

Associate Prof at University of South Africa | South Africa

Dr. Letitia Pienaar is a distinguished academic, attorney, and researcher specializing in mental health law, medical jurisprudence, and criminal justice. Currently an Associate Professor at the University of South Africa, she brings decades of expertise in higher education, legal practice, and multidisciplinary research. Her work bridges law, health, and ethics, with a strong focus on disability rights, forensic mental health, and inclusive education. Having served on numerous advisory boards, professional committees, and international collaborations, Dr. Pienaar combines practical legal experience with academic leadership, contributing significantly to policy, legal reform, and the advancement of justice in healthcare and mental health systems.

Publication Profile 

Google Scholar

Education 

Dr. Letitia Pienaar holds an LL.D in Mental Health Law and the Criminal Justice System from the University of South Africa, along with an LL.M specializing in Medical Jurisprudence, HIV/AIDS Law, and Delictual Damages. She completed advanced certificates in Medicine and Law, Child Law, National Credit Act implications, and Disability Rights in Africa from the Universities of Pretoria and South Africa. Her foundational degree, LL.B, was obtained from Rand Afrikaans University. Additionally, she is a certified assessor in higher education and has undertaken training in inclusive education, healthcare rights, and bioethics, complementing her extensive legal and academic qualifications.

Experience 

Dr. Letitia Pienaar is an Associate Professor at the University of South Africa, lecturing in Medical Law, Forensic Medicine, and Criminal Law while supervising postgraduate research. She previously served as Senior Legal Specialist at First National Bank, focusing on legal compliance and regulatory matters. Her legal career began at Hofmeyr Herbstein & Gihwala Inc, specializing in litigation for corporate clients. Beyond academia, she has contributed to research ethics committees, disability rights advocacy, and policy development initiatives. Her expertise spans higher education, legal drafting, research ethics, and medical law, with substantial experience managing academic programs, research collaborations, and interdisciplinary legal-healthcare projects.

Awards and Honors 

Dr. Letitia Pienaar has been recognized for her academic excellence, professional contributions, and leadership in law and health ethics. She has served on advisory boards such as the University of Washington Delphi Study on mental health and AIDS in African prisons and as a member of the International Association of Forensic Mental Health’s Equality, Diversity, and Inclusion Committee. Her role in inclusive education and healthcare working streams for the D20 underscores her international standing. She has also contributed to UNESCO’s Bioethics initiatives and African mental health forums, reflecting her commitment to advancing human rights, legal reform, and healthcare justice.

Research Focus 

Dr. Letitia Pienaar research focuses on the intersection of law, health, and human rights, with particular emphasis on mental health law, forensic medicine, and disability rights. She explores ethical, legal, and policy dimensions in healthcare, criminal justice, and inclusive education. Her work addresses HIV/AIDS law, child protection, forensic mental health, and bioethics, integrating legal research with public health imperatives. Through advisory roles, academic publications, and postgraduate supervision, she advances interdisciplinary scholarship that informs legal reforms, healthcare regulations, and human rights protections. Her research contributes to building inclusive legal-health frameworks and shaping discourse around mental health justice and medical law ethics.

Publication Top Notes

Investigating the reasons behind the increase in medical negligence claims

Considering Mental Health Courts for South Africa: Lessons from Canada and the United States of America

Deciphering the Composition of Section 79-Assessment Panels in the Criminal Procedure Amendment Act 4 of 2017

Determination of criminal capacity for child offenders-interfacing the procedural requirements of the Child Justice and Criminal Procedure Act

Plausible subjective experience versus fallible corroborative evidence: The formulation of insanity in Nigerian criminal courts

The unfit accused in the South African criminal justice system: From automatic detention to unconditional release

The DSM-5 and the role of personality disorders under the criminal law

Access to the medical records of a child: legislative review required

Compulsory HIV testing of child sex offenders in the South African criminal justice system

Facilitating a framework for managing rare diseases in South Africa: Comparative insights from the UK and Italy

Priorities for addressing mental health conditions and substance use disorders in prisons in sub-Saharan Africa: expert consensus from a Delphi panel

The Evolution of Mental Health Legislation in South Africa: Towards a Rights-Based Approach

Low-threshold fitness test in South Africa and the USA : consequences for the fit but mentally ill accused

Mentally ill accused in South African criminal procedure Evaluating the mental health court model as therapeutic response:

Conclusion

Dr. Letitia Pienaar demonstrates outstanding academic, research, and professional achievements that align strongly with the criteria for the Best Researcher Award. Her interdisciplinary expertise in law, mental health, and human rights, combined with significant teaching, publication, and professional engagement experience, make her an ideal candidate. With further expansion into global research collaborations and high-impact international publications, she has the potential to become a leading voice in her field worldwide.

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

Prof. Dr. Josep Allué Creus, Apdena Consult, Spain

Prof. Dr. Josep Allué Creus 🧪🌿 is a renowned Doctor of Pharmacy and expert in phytotherapy. A retired Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🎓, he co-directs the Master’s and Postgraduate Programs in Phytotherapy at IL3, University of Barcelona 💻📘. He serves as the spokesperson for Medicinal Plants and Homeopathy at the College of Pharmacists of Barcelona 💊 and is a founding member and treasurer of SEFIT. As part of AEEM’s Natural Products group 👩‍⚕️, his research integrates botanical science and women’s health, making him a leader in herbal medicine 🌸🔬.

Publication Profile

Orcid

Education

Prof. Dr. Josep Allué Creus 🎓🧪 exemplifies academic excellence with a prestigious Doctorate in Pharmacy, laying the cornerstone for his remarkable contributions to the fields of phytotherapy and medicinal plant sciences 🌿📚. His doctoral foundation reflects a deep-rooted dedication to advancing healthcare through botanical knowledge and evidence-based research 🔬💊. Prof. Allué’s commitment to scientific integrity and innovation has positioned him as a respected authority in natural medicine 🌱, influencing both academic circles and clinical applications. His passion for teaching and research continues to inspire the next generation of pharmacists and phytotherapy experts across Spain and beyond 🌍👨‍🏫.

Experience

Prof. Dr. Josep Allué Creus 📘🌿 has made significant academic and teaching contributions as a Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🏛️. Throughout his career, he nurtured and mentored countless students, shaping future generations of scientists, pharmacists, and healthcare professionals 👩‍⚕️🧑‍🔬. His passion for education did not end with retirement—he continues to share his expertise as a co-director of master’s and postgraduate programs in phytotherapy through IL3 at the University of Barcelona 🎓🌱. Prof. Allué’s unwavering dedication to lifelong learning and botanical sciences remains a beacon of inspiration in academic circles 🔬📖.

Research Focus

Prof. Dr. Josep Allué Creus 🧠🌿 focuses on two dynamic research domains: phytotherapy and neurodegenerative diseases. His pioneering work on medicinal plant extracts 🌱, such as hemp-derived compounds, highlights their therapeutic potential for conditions like gastrointestinal disorders and dyspepsia 💊. Parallelly, he contributes extensively to cutting-edge Alzheimer’s research, especially in biomarker development for early detection of cognitive decline 🧬🧪. His publications delve into plasma-based assays for amyloid and tau proteins, advancing non-invasive diagnostics in neurology 🧫🔍. Bridging natural medicine and modern neurobiology, Prof. Allué champions holistic innovation in health science.

Publication Top Notes

Hemp Extract (<i>Extractum Cannabis</i>) in the Treatment of Gastrointestinal Distress and Dyspepsia: Historical Insights from Barcelona, Spain

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline

Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity

Detecting amyloid positivity in early Alzheimer’s disease using combinations of plasma Aβ42/Aβ40 and p-tau

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations

Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort

The global Alzheimer’s Association round robin study on plasma amyloid β methods

Plasma amyloid, phosphorylated tau, and neurofilament light for individualized risk prediction in mild cognitive impairment

Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease